Peripheral vascular health
Trial information
Explore Peripheral Vascular Health (PVH) clinical trials, focused on advancing treatments and improving therapies for vascular conditions.
Clinical trials at PVH
Discover active, enrolling, and completed studies that drive innovation and improve patient outcomes in vascular care.
Onyx™ Liquid Embolic Clinical Study
Purpose: To evaluate how safe and effective the Onyx™ liquid embolic system is for people who have active bleeding in the peripheral vasculature outside the heart and brain. The study is done at multiple centers within the United States, and everyone in the study will get the same treatment (no one will be randomly assigned to different groups).
Sexes eligible:
All
Age:
22+
Study type:
Pivotal
Sites:
25
Status:
Enrolling
Location:
United States
IN.PACT™ Global Clinical Study
Purpose: To collect safety and effectiveness data on the IN.PACT™ Admiral™ drug-coated balloon (DCB) for the treatment of artery disease in the leg, using real-world patients. The study was global, done at multiple centers, and everyone in the study received the same treatment.
Sexes eligible:
All
Age:
18+
Study type:
Post-market
Sites:
65
Status:
Completed
Location:
Global
Learn more about PAD and treatment options.
VenaSeal™ Spectrum: Global Post-Market Trial
Purpose: To compare the VenaSeal™ closure system to surgery or heat-based treatment for treating early and advanced vein disease near the surface of the skin. The study was global, done at multiple centers, and patients were randomly assigned to different treatment groups.
Sexes eligible:
All
Age:
18+
Study type:
Post-market
Sites:
32
Status:
Completed
Location:
Global
Learn more about vein disease and treatment options.
ABRE™ Clinical Study
Purpose: To evaluate how safe and effective the Abre™ venous self-expanding stent system is for treating blocked veins in the hip and upper leg in people with vein disease. The study was global, done at multiple centers, and all patients received the same treatment.
Sexes eligible:
All
Age:
18–80 years
Study type:
Pivotal and post-market
Sites:
24
Status:
Completed
Location:
Global
Ellipsys™ Post Market Surveillance Study
Purpose: To assess how safe and effective the Ellipsys™ vascular access system device and procedure is for creating a connection between blood vessels (fistulas) in the arm for patients on dialysis. The connection is made using a minimally invasive method. The study was done in multiple centers across the United States and all patients received the same treatment.
Sexes eligible:
All
Age:
18–80 years
Study type:
Post-market
Sites:
12
Status:
Completed
Location:
United States
Learn more about end-stage kidney disease (ESKD) and management options.
IN.PACT™ AV Access Post-Approval Study
Purpose: To evaluate the long-term safety of the IN.PACT™ AV drug-coated balloon (DCB) for treatment of new or non-stented narrowed areas in blood vessel connections (fistulas) in the arm for dialysis patients. The study is done at multiple centers, and all patients receive the same treatment.
Sexes eligible:
All
Age:
21+ years
Study type:
Post-market
Sites:
20
Status:
Active, not enrolling
Location:
United States
Product surveillance registry
Purpose: The purpose of this registry is to report the safety and effectiveness of approved Medtronic products. The information helps patients, doctors, hospitals, and others by making it easier to monitor product performance and improve care.
Sexes eligible:
All
Age:
All
Study type:
Post-market
Sites:
382
Status:
Enrolling
Location:
Global